NewsNew nanoparticle drug combination for atherosclerosis
developed

17th June 2020by admin0
https://nfusion-tech.com/wp-content/uploads/2020/06/new-nanoparticle-drug-combination-for-atherosclerosisdeveloped_5eeb24e5d7505.jpeg

Physicochemical cargo-switching nanoparticles (CSNP)
designed by KAIST can help significantly reduce cholesterol and
macrophage foam cells in arteries, which are the two main triggers
for atherosclerotic plaque and inflammation.

Leave a Reply

Your email address will not be published. Required fields are marked *

https://nfusion-tech.com/wp-content/uploads/2019/10/Logo_newfusion-footer.png
https://nfusion-tech.com/wp-content/uploads/2019/10/Logo_newfusion-footer.png
Subscribe

If you wish to receive our latest news in your email box, just subscribe to our newsletter. We won’t spam you, we promise!

    New Fusion

    The New Fusion technology is based on a phenomenon called triplet-triplet annihilation (TTA) which is a process in which two triplet excitons annihilate and produce a higher energy singlet exciton.

    Subscribe

    If you wish to receive our latest news in your email box, just subscribe to our newsletter. We won’t spam you, we promise!

      New Fusion

      The New Fusion technology is based on a phenomenon called triplet-triplet annihilation (TTA) which is a process in which two triplet excitons annihilate and produce a higher energy singlet exciton.

      Copyright @2020 New Fusion All Rights Reserved

      Designed by FallingBrick


      Warning: Creating default object from empty value in /homepages/9/d775151175/htdocs/nfusion-tech.com/wp-content/plugins/applauz/framework_bt_plugin/.framework_bt_plugin.php on line 1640